Attention Deficit Hyperactivity Disorder (ADHD) Management

Diagnostic Criteria

• Symptoms must persist for at least 6 months, and several symptoms must have been present before age 12 years, with evidence of functional impairment in social, academic, or occupational functioning, as recommended by the American Academy of Pediatrics 1
• Symptoms are not better explained by oppositional behavior, defiance, hostility, another mental disorder, substance intoxication or withdrawal, and must be present in 2 or more settings (e.g., home, school, work), as suggested by the American Academy of Pediatrics 1
• Symptoms of inattention and/or hyperactivity/impulsivity must be present in multiple settings (e.g., work, home, social environments) to meet the diagnostic criteria, as recommended by the American Academy of Pediatrics and supported by the DSM-5 criteria 2, 3

Assessment Tools

• The Adult ADHD Self-Report Scale (ASRS-V1.1) is recommended for adults, with a positive screen occurring when a patient checks "often" or "very often" for 4 or more of the 6 questions, as recommended by the American Academy of Pediatrics 1
• Behavioral checklists from parents and teachers/childcare providers are suggested for children aged 4-6, as recommended by the American Academy of Pediatrics 4
• A comprehensive assessment should include a detailed developmental history, academic/occupational functioning, social relationships, family history, and environmental factors, as recommended by the Pediatrics journal 4
• Information for assessing ADHD symptoms should be obtained from multiple sources, including parents/guardians, teachers, and mental health clinicians, as recommended by the American Academy of Pediatrics 3

Comorbid Conditions

• Adolescents with ADHD are at risk for substance use, particularly marijuana, which can mimic ADHD symptoms, as noted by the American Academy of Pediatrics 4
• Comorbid conditions, including substance use, depression, and anxiety, should be considered, as recommended by the American Academy of Pediatrics 4
• The following conditions should be ruled out due to their potential to mimic ADHD symptoms: thyroid disorders, sleep disorders, seizure disorders, and medication side effects, as recommended by the Pediatrics journal 4
• Other psychiatric conditions, such as anxiety disorders, mood disorders, learning disabilities, autism spectrum disorders, and substance use disorders, should be distinguished from ADHD, according to the Pediatrics journal 4
• The key differences between ADHD and comorbid conditions, such as bipolar disorder, are highlighted in the following table:

Intervention and Management

• Parent Training and Behavioral Management (PTBM) is recommended as first-line intervention before finalizing diagnosis, as recommended by the American Academy of Pediatrics 4
• Behavioral interventions can help clarify diagnosis and may be sufficient for children with milder symptoms, as suggested by the American Academy of Pediatrics 4
• First-line treatment with FDA-approved stimulant medications, such as methylphenidate or amphetamine derivatives, is recommended for children aged 6 and above, starting at lower doses and titrating slowly, with monitoring for cardiovascular effects, as recommended by the American Academy of Pediatrics 2, 3
• For children aged 4-6 years, evidence-based parent training and behavioral management are recommended as first-line treatment, with methylphenidate considered if behavioral interventions are insufficient, as recommended by the American Academy of Pediatrics 3
• For adolescents aged 12-18 years, FDA-approved medications for ADHD should be used with the adolescent's assent, along with educational interventions and behavioral supports, as recommended by the American Academy of Pediatrics 3
• Extended-release clonidine is a second-line treatment option for ADHD, as recommended by the American Academy of Pediatrics, if stimulants are contraindicated, poorly tolerated, or ineffective 2
• Cognitive-behavioral therapy focused on organization skills, time management, and emotional regulation can be an effective non-pharmacological intervention for ADHD, with a moderate strength of evidence, as recommended by the American Psychological Association 6

Ongoing Monitoring and Follow-up

• Clinicians should assess the impact of ADHD symptoms on academic performance, relationships with friends and family, and daily activities, to develop a comprehensive treatment plan, and screen for comorbid conditions, including emotional/behavioral disorders, developmental conditions, and physical conditions, as recommended by the American Academy of Pediatrics 4
• Clinicians should establish a clear follow-up schedule based on symptom stability, with monthly visits until symptoms are stabilized, and adjusting frequency based on medication response, side effects, and comorbidities, with baseline measurements documented for ongoing monitoring, as recommended by the American Academy of Child and Adolescent Psychiatry 7
• Clinicians should be aware of the potential for misattribution of symptoms to normal aging, depression, or anxiety, and should carefully assess for comorbidities and document impairment across settings, with a high strength of evidence, as recommended by the American Medical Association 6
• Clinicians should ask about the impact of ADHD symptoms on driving, medication coverage during driving times, and any traffic violations or close calls while driving, as recommended by multiple sources 3